Single-nucleotide polymorphisms and haplotypes in the adiponectin gene contribute to the genetic risk for type 2 diabetes in Tunisian Arabs

Diabetes Research and Clinical Practice

Volumn 97, Issue 2, 2012, Pages 290-297

  Mtiraoui, Nabil ^a,b   Ezzidi, Intissar ^a   Turki, Amira ^a   Chaieb, Arbi ^c   Mahjoub, Touhami ^a   Almawi, Wassim Y ^d  

^a UNIVERSITY OF MONASTIR   (Tunisia)

^b UNIVERSITY OF MONASTIR   (Tunisia)

^c FARHAT HACHED HOSPITAL   (Tunisia)

^d ARABIAN GULF UNIVERSITY   (Bahrain)

Author keywords

Adiponectin; Allele; Haplotype; Tunisia; Type 2 diabetes

Indexed keywords

ADIPONECTIN; CHOLESTEROL; CREATININE; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; UREA;

3' UNTRANSLATED REGION; ADIPONECTIN GENE; ADULT; ALLELE; ARAB; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; EXON; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC MODEL; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; HYPERTENSION; INTRON; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; TUNISIAN ARAB; UREA BLOOD LEVEL;

ADIPONECTIN; ARABS; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; OBESITY; POLYMORPHISM, SINGLE NUCLEOTIDE; TUNISIA;

EID: 84865067173     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2012.02.015     Document Type: Article

References (38)

1. Cnop M., Havel P.J., Utzschneider K.M., Carr D.B., Sinha M.K., Boyko E.J., et al. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 2003, 4:459-469.
2. Ziemke F., Mantzoros C.S. Adiponectin in insulin resistance: lessons from translational research. Am J Clin Nutr 2010, 91:258S-261S.
3. Gable D.R., Hurel S.J., Humphries S.E. Adiponectin and its gene variants as risk factors for insulin resistance, the metabolic syndrome and cardiovascular disease. Atherosclerosis 2006, 188:231-244.
4. Heid I.M., Wagner S.A., Gohlke H., Iglseder B., Mueller J.C., Cip P., et al. Genetic architecture of the APM1 gene and its influence on adiponectin plasma levels and parameters of the metabolic syndrome in 1,727 healthy Caucasians. Diabetes 2006, 55:375-384.
5. Côté M., Cartier A., Reuwer A.Q., Arsenault B.J., Lemieux I., Després J.P., et al. Adiponectin and risk of coronary heart disease in apparently healthy men and women (from the EPIC-Norfolk Prospective Population Study). Am J Cardiol 2011, 108:367-373.
6. 2. Nutr Res 2011, 31:378-386.
7. Liu J., Wang F., Cha Y., Chen Z.P., Ding H.Y. Adiponectin levels in non-obese first-degree relatives of type 2 diabetes patients and non-diabetic subjects: a 5-year follow-up study. J Int Med Res 2010, 38:792-802.
8. Pyrzak B., Ruminska M., Popko K., Demkow U. Adiponectin as a biomarker of the metabolic syndrome in children and adolescents. Eur J Med Res 2010, 15(Suppl 2):147-151.
9. Medina-Bravo P., Meza-Santibáñez R., Rosas-Fernández P., Galván-Duarte R., Saucedo-García R., Velázquez-López L., et al. Decrease in serum adiponectin levels associated with visceral fat accumulation independent of pubertal stage in children and adolescents. Arch Med Res 2011, 42:115-121.
10. Hung J., McQuillan B.M., Thompson P.L., Beilby J.P. Circulating adiponectin levels associate with inflammatory markers, insulin resistance and metabolic syndrome independent of obesity. Int J Obes (Lond) 2008, 32:772-779.
11. Hivert M.F., Manning A.K., McAteer J.B., Florez J.C., Dupuis J., Fox C.S., et al. Common variants in the adiponectin gene (ADIPOQ) associated with plasma adiponectin levels, type 2 diabetes, and diabetes-related quantitative traits: the Framingham Offspring Study. Diabetes 2008, 57:3353-3359.
12. Takahashi M., Arita Y., Yamagata K., Matsukawa Y., Okutomi K., Horie M., et al. Genomic structure and mutations in adipose-specific gene, adiponectin. Int J Obes Relat Metab Disord 2000, 24:861-868.
13. Francke S., Manraj M., Lacquemant C., Lecoeur C., Leprêtre F., Passa P., et al. A genome-wide scan for coronary heart disease suggests in Indo-Mauritians a susceptibility locus on chromosome 16p13 and replicates linkage with the metabolic syndrome on 3q27. Hum Mol Genet 2001, 10:2751-2765.
14. Gibson F., Froguel P. Genetics of the APM1 locus and its contribution to type 2 diabetes susceptibility in French Caucasians. Diabetes 2004, 53:2977-2983.
15. Li Y., Li X., Shi L., Yang M., Yang Y., Tao W., et al. Association of adiponectin SNP+45 and SNP+276 with type 2 diabetes in Han Chinese populations: a meta-analysis of 26 case-control studies. PLoS One 2011, 6:e19686.
16. Siitonen N., Pulkkinen L., Lindström J., Kolehmainen M., Eriksson J.G., Venojärvi M., et al. Association of ADIPOQ gene variants with body weight, type 2 diabetes and serum adiponectin concentrations: the Finnish Diabetes Prevention Study. BMC Med Genet 2011, 12:5.
17. Park J.W., Park J., Jee S.H. ADIPOQ gene variants associated with susceptibility to obesity and low serum adiponectin levels in healthy Koreans. Epidemiol Health 2011, 33:e2011003.
18. Vasseur F., Helbecque N., Dina C., Lobbens S., Delannoy V., Gaget S., et al. Single-nucleotide polymorphism haplotypes in the both proximal promoter and exon 3 of the APM1 gene modulate adipocyte-secreted adiponectin hormone levels and contribute to the genetic risk for type 2 diabetes in French Caucasians. Hum Mol Genet 2002, 11:2607-2614.
19. Tso A.W., Sham P.C., Wat N.M., Xu A., Cheung B.M., Rong R., et al. Polymorphisms of the gene encoding adiponectin and glycaemic outcome of Chinese subjects with impaired glucose tolerance: a 5-year follow-up study. Diabetologia 2006, 49:1806-1815.
20. Gong M., Long J., Liu Q., Deng H.C. Association of the ADIPOQ rs17360539 and rs266729 polymorphisms with type 2 diabetes: a meta-analysis. Mol Cell Endocrinol 2010, 325:78-83.
21. Szopa M., Malczewska-Malec M., Kiec-Wilk B., Skupien J., Wolkow P., Malecki M.T., et al. Variants of the adiponectin gene and type 2 diabetes in a Polish population. Acta Diabetol 2009, 46:317-322.
22. Vasseur F., Leprêtre F., Lacquemant C., Froguel P. The genetics of adiponectin. Curr Diab Rep 2003, 3:151-158.
23. Vionnet N., Tregouët D., Kazeem G., Gut I., Groop P.H., Tarnow L., et al. Analysis of 14 candidate genes for diabetic nephropathy on chromosome 3q in European populations: strongest evidence for association with a variant in the promoter region of the adiponectin gene. Diabetes 2006, 55:3166-3174.
24. Mohammadzadeh G., Zarghami N. Associations between single-nucleotide polymorphisms of the adiponectin gene, serum adiponectin levels and increased risk of type 2 diabetes mellitus in Iranian obese individuals. Scand J Clin Lab Invest 2009, 69:764-771.
25. Richards J.B., Waterworth D., O'Rahilly S., Hivert M.F., Loos R.J., Perry J.R., et al. A genome-wide association study reveals variants in ARL15 that influence adiponectin levels. PLoS Genet 2009, 5:e1000768.
26. Han L.Y., Wu Q.H., Jiao M.L., Hao Y.H., Liang L.B., Gao L.J., et al. Associations between single-nucleotide polymorphisms (+45T>G, +276G>T, -11377C>G, -11391G>A) of adiponectin gene and type 2 diabetes mellitus: a systematic review and meta-analysis. Diabetologia 2011, (June). [Epub ahead of print].
27. Olckers A., Towers G.W., van der Merwe A., Schwarz P.E., Rheeder P., Schutte A.E. Protective effect against type 2 diabetes mellitus identified within the ACDC gene in a black South African diabetic cohort. Metabolism 2007, 56:587-592.
28. Ukkola O., Santaniemi M., Rankinen T., Leon A.S., Skinner J.S., Wilmore J.H., et al. Adiponectin polymorphisms, adiposity and insulin metabolism: HERITAGE family study and Oulu diabetic study. Ann Med 2005, 37:141-150.
29. Wassel C.L., Pankow J.S., Jacobs D.R., Steffes M.W., Li N., Schreiner P.J. Variants in the adiponectin gene and serum adiponectin: the Coronary Artery Development in Young Adults (CARDIA) Study. Obesity (Silver Spring) 2010, 18:2333-2338.
30. Kaklamani V., Yi N., Zhang K., Sadim M., Offit K., Oddoux C., et al. Polymorphisms of ADIPOQ and ADIPOR1 and prostate cancer risk. Metabolism 2011, 60:1234-1243.
31. Hegener H.H., Lee I.M., Cook N.R., Ridker P.M., Zee R.Y. Association of adiponectin gene variations with risk of incident myocardial infarction and ischemic stroke: a nested case-control study. Clin Chem 2006, 52:2021-2027.
32. Gu H.F., Abulaiti A., Ostenson C.G., Humphreys K., Wahlestedt C., Brookes A.J., et al. Single nucleotide polymorphisms in the proximal promoter region of the adiponectin (APM1) gene are associated with type 2 diabetes in Swedish Caucasians. Diabetes 2004, 53(Suppl 1):S31-S35.
33. Wang Y., Zhang D., Liu Y., Yang Y., Zhao T., Xu J., et al. Association study of the single nucleotide polymorphisms in adiponectin-associated genes with type 2 diabetes in Han Chinese. J Genet Genomics 2009, 36:417-423.
34. Chiodini B.D., Specchia C., Gori F., Barlera S., D'Orazio A., Pietri S., et al. Adiponectin gene polymorphisms and their effect on the risk of myocardial infarction and type 2 diabetes: an association study in an Italian population. Ther Adv Cardiovasc Dis 2010, 4:223-230.
35. Yang M., Qiu C.C., Chen W., Xu L.L., Yu M., Xiang H.D. Identification of a regulatory single nucleotide polymorphism in the adiponectin (APM1) gene associated with type 2 diabetes in Han nationality. Biomed Environ Sci 2008, 21:454-459.
36. Wassel C.L., Pankow J.S., Rasmussen-Torvik L.J., Li N., Taylor K.D., Guo X., et al. Associations of SNPs in ADIPOQ and subclinical cardiovascular disease in the multi-ethnic study of atherosclerosis (MESA). Obesity (Silver Spring) 2011, 19:840-847.
37. Du W., Li Q., Lu Y., Yu X., Ye X., Gao Y., et al. Genetic variants in ADIPOQ gene and the risk of type 2 diabetes: a case-control study of Chinese Han population. Endocrine 2011, (May). [Epub ahead of print].
38. Ying S.Y., Lin S.L. Intron-derived microRNAs - fine tuning of gene functions. Gene 2004, 342:25-28.